More on RNAC
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $6.41 |
|
|||
| Open | $6.38 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $6.52 | ||||
| Day Low | $6.11 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 85,902 | ||||
- Cartesian Therapeutics Announces New Employment Inducement Grants
- H.C. Wainwright Reiterates Buy Rating on Cartesian Therapeutics (RNAC)
- Form 8-K Cartesian Therapeutics, For: Sep 29
- Cartesian reports retreatment data for Descartes-08 in myasthenia gravis
- Cartesian Therapeutics Announces Additional Retreatment Data for Descartes-08 Highlighting Deep and Durable Responses in Patients with Myasthenia Gravis
- Form SCHEDULE 13G Cartesian Therapeutics, Filed by: BARCLAYS PLC
- Cartesian Therapeutics Announces New Employment Inducement Grants
- Cartesian Therapeutics (RNAC) Tops Q2 EPS by 134c
- Form 10-Q Cartesian Therapeutics, For: Jun 30
- Form 8-K Cartesian Therapeutics, For: Aug 06
Entities mentioned with RNAC
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Earnings | View Related Stories »
- H.C. Wainwright | View Related Stories »
- 13D | View Related Stories »
- Show More...
